Community post

Dr Ameneh Khatami (University of Sydney, Phage Australia) has been awarded $4.3 million to investigate the use of a locally produced two-phage combination that targets S. aureus to see if it provides an advantage in addition to antibiotics in treating patients with severe bloodstream infections.